Date: 2015-05-07
Type of information: Nomination
Compound:
Company: Kiadis Pharma (The Netherlands)
Therapeutic area: Cancer - Oncology
Type agreement: nomination
Action mechanism:
Disease:
Details: * On May 7, 2015, Kiadis Pharma announced the appointment of Dr. Vincent Brichard as an independent member of its Supervisory Board. Dr. Brichard has more than 25 years’ experience in the oncology and immunology field, including almost 15 years at GSK where he was Senior Vice-President and had responsibility for the Immunotherapeutics Business Unit, which covered a broad, integrated approach to immunotherapy – from bench discovery through clinical development and operations to regulatory and commercial activities. In addition to this position, he served as a member of the Board of Directors at GSK Biologicals. Dr. Brichard is a physician by training and holds a PhD in tumor immunology. He began his academic career at the Ludwig Institute for Cancer Research, Brussels Branch, followed by positions at the Institut Curie Cancer Center, Paris, and at the University of Louvain, Brussels. He further holds an MBA from the Harvard Business School.
Financial terms:
Latest news:
